MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/16/2026, 06:18 AM (Berlin time), refresh in progress.

Doximity Stock

Doximity, Inc.

DOCSNYSEMarkt
US$31.50
+5.3% today

Company data

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
United States
CEO
Jeffrey A. Tangney
Employees
880
Market cap
$5.6 B
IPO
24/06/2021

Doximity, Inc. is a healthcare company operating within the Medical - Healthcare Information Services industry. The company provides a cloud-hosted digital platform specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools that empower its…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

Doximity stock: price history

15/10/25-53.7 %15/10/26

1D

+5.3%

1W

+7.2%

1M

+22.0%

6M

+29.9%

YTD

-28.9%

1Y

-53.7%

2Y

-28.2%

5Y

-54.9%

10Y

–

Next earnings date

Next earnings date

05/11/2026 (in 19 days)

Volatility around earnings

~164% stronger price swings than usual

Ask the agents about Doximity

Analyst assessment of Doximity

PRICE TARGET LOW

US$18.00

CONSENSUS

US$27.00

MEDIAN

US$25.50

PRICE TARGET HIGH

US$41.00

1

STRONG BUY

8

BUY

13

HOLD

2

SELL

0

STRONG SELL

24

TOTAL · Hold

As of: 29/09/2026

ANALYST FIRMRATINGACTIONDATE
Evercore ISI GroupIn Linemaintain29/09/2026
Freedom Capital MarketsBuy → Holddowngrade08/09/2026
BarclaysEqual Weightmaintain21/08/2026
Truist SecuritiesHoldmaintain13/08/2026
Wells FargoEqual Weight → Underweightdowngrade10/08/2026
Piper SandlerOverweightmaintain07/08/2026
JP MorganNeutralmaintain07/08/2026
Evercore ISI GroupIn Linemaintain07/08/2026

Doximity stock metrics

P/E

35.39

P/B

6.28

EV/EBITDA

22.1

RETURN ON EQUITY

2.7%

NET MARGIN

15.5%

DEBT/EQUITY

0.01

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

97.0%

FLOAT SHARES

172,840,318

AVG. DAILY VOLUME (30D)

3,075,675

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Sitaram Siddharth

OfficerSale2,61330.68Pre-planned16/10/2026

Sitaram Siddharth

OfficerConversion8,000–Pre-planned16/10/2026

Wampler Kira Scherer

DirectorConversion2,000–Pre-planned05/10/2026

Wampler Kira Scherer

DirectorSale2,00028.91Pre-planned05/10/2026

Yang Watkin Phoebe L.

DirectorSale1,29026.71Pre-planned02/10/2026
Page 1 / 8

Attention

1 mention today in US forums, about the same as yesterdayPrice since yesterday: +5.3%

Forums (Reddit)

26/0828/0810/10

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
Apella Capital, LLC59,488+80230/09/2026
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC49,620+31,35430/09/2026
Park Capital Management, LLC / WI14,540+14,54030/09/2026
ANCHYRA PARTNERS LLC11,638+11,63830/09/2026
Able Wealth Management LLC7,232+7,23230/09/2026
Page 1 / 3

Comparable stocks

Frequently asked questions about Doximity stock

What does Doximity do?

Doximity, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.

The CEO is Jeffrey A. Tangney, the company employs around 880 people.

The IPO was on 24/06/2021; the stock trades on NYSE under the ticker DOCS.

What do analysts say about Doximity stock?

24 analysts rate the stock, the consensus is Hold (as of 29/09/2026).

The average price target is US$27.00, ranging from US$18.00 to US$41.00, with a median of US$25.50.

This is an external assessment, not a statement by Market Jury.

When does Doximity report next?

The next earnings date is 05/11/2026.

Around past earnings, price swings were roughly 164% stronger than usual.

Does Doximity pay a dividend?

No, Doximity currently does not pay a dividend.

Which stocks are comparable to Doximity?

Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.

How can I get Doximity stock analyzed?

Clicking "Analyze stock" lets five strategies assess Doximity against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.